Marine Actinomycetes: A New Source of Compounds against Malaria
Author Information
Author(s): Prudhomme Jacques, McDaniel Eric, Ponts Nadia, Bertani Stéphane, Fenical William, Jensen Paul, Le Roch Karine
Primary Institution: University of California Riverside
Hypothesis
Can compounds derived from marine actinomycetes inhibit the growth of the malaria parasite?
Conclusion
Salinosporamide A shows strong potential as an antimalarial agent by inhibiting the growth of the malaria parasite in vitro and in vivo.
Supporting Evidence
- Salinosporamide A inhibited the proliferation of the malaria parasite at an IC50 of 11.4 nM.
- The compound showed strong inhibitory activity against the erythrocytic stages of the malaria parasite.
- Salinosporamide A protected mice against malaria infection at low dosages.
- Both salinosporamide A and the proteasome inhibitor MG-132 increased ubiquitin conjugate proteins in parasite extracts.
Takeaway
Scientists found a new medicine from ocean bacteria that can help fight malaria by stopping the parasite from growing.
Methodology
The study screened 80 bacterial crude extracts for their activity against malaria growth and tested the pure compound salinosporamide A in vitro and in vivo.
Limitations
The safety profile of salinosporamide A for treating malaria needs further evaluation.
Statistical Information
P-Value
7.9 E-04
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website